Tissue-engineered heart valve: Future of cardiac surgery

World Journal of Surgery

Volumn 36, Issue 7, 2012, Pages 1581-1591

  Rippel, Radoslaw A ^a   Ghanbari, Hossein ^a   Seifalian, Alexander M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE SCAFFOLD;

BIOPROSTHESIS; BIOREACTOR; ENDOTHELIUM CELL; FIBROBLAST; HEART VALVE PROSTHESIS; HUMAN; METHODOLOGY; REVIEW; STEM CELL; TISSUE ENGINEERING;

BIOPROSTHESIS; BIOREACTORS; ENDOTHELIAL CELLS; FIBROBLASTS; HEART VALVE PROSTHESIS; HUMANS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84864283656     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-012-1535-y     Document Type: Article

References (72)

1. Angele P, Yoo JU, Smith C et al (2003) Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro. J Orthop Res 21(3):451-457 (Pubitemid 36546811)
2. Barili F, Dainese L, Topkara VK et al (2005) The future of human valve allografts: bioengineering and stem cells. Artif Organs 29(11):923 (Pubitemid 43943049)
3. Barili F, Dainese L, Cheema FH et al (2009) Bioengineering of the aortic valve: a race without a finish line. Artif Organs 33(1): 86-87
4. Barrilleaux B, Phinney DG, Prockop DJ et al (2006) Review: ex vivo engineering of living tissues with adult stem cells. Tissue Eng 12(11):3007-3019 (Pubitemid 44846407)
5. Barron V, Lyons E, Stenson-Cox C et al (2003) Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 31(9):1017-1030
6. Boretos JW, Pierce WS (1967) Segmented polyurethane: a new elastomer for biomedical applications. Science 158(807):1481-1482
7. Cebotari S, Tudorache I, Jaekel T et al (2010) Detergent decellularization of heart valves for tissue engineering: toxicological effects of residual detergents on human endothelial cells. Artif Organs 34(3):206-210
8. Christenson EM, Dadsetan M, Wiggins M et al (2004) Poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo studies. J Biomed Mater Res 69(3):407-416
9. Christenson EM, Anderson JM, Hiltner A (2004) Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J Biomed Mater Res A 70(2):245-255 (Pubitemid 38988755)
10. Christenson EM, Dadsetan M, Hiltner A (2005) Biostability and macrophage-mediated foreign body reaction of silicone-modified polyurethanes. J Biomed Mater Res A 74(2):141-155 (Pubitemid 40995528)
11. De VG, Lebacq A, Mesure L et al (2010) The remodeling of cardiovascular bioprostheses under influence of stem cell homing signal pathways. Biomaterials 31(1):20-28
12. Dohmen PM, Konertz W (2009) Tissue-engineered heart valve scaffolds. Ann Thorac Cardiovasc Surg 15(6):362-367
13. Driessen NJ, Mol A, Bouten CV et al (2007) Modeling the mechanics of tissue-engineered human heart valve leaflets. J Biomech 40(2):325-334 (Pubitemid 44958586)
14. Dumont K, Yperman J, Verbeken E et al (2002) Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs 26(8):710-714 (Pubitemid 34985100)
15. Eaglstein WH, Falanga V (1997) Tissue engineering and the development of Apligraf, a human skin equivalent. Clin Ther 19(5):894-905 (Pubitemid 27508925)
16. Engelmayr GC Jr, Sales VL, Mayer JE Jr et al (2006) Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues. Biomaterials 27(36):6083-6095 (Pubitemid 44414977)
17. Filova E, Straka F, Mirejovsky T et al (2009) Tissue-engineered heart valves. Physiol Res 58(Suppl 2):S141-S158
18. Freed LE, Guilak F, Guo XE et al (2006) Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng 12(12):3285-3305 (Pubitemid 46037157)
19. Gandaglia A, Bagno A, Naso F et al (2011) Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardiothorac Surg 39(4):523-531
20. Ghanbari H, Viatge H, Kidane AG et al (2009) Polymeric heart valves: new materials, emerging hopes. Trends Biotechnol 27(6): 359-367
21. Ghanbari H, Kidane AG, Burriesci G et al (2010) The anti-calcification potential of a silsesquioxane nanocomposite polymer under in vitro conditions: potential material for synthetic leaflet heart valve. Acta Biomater 6(11):4249-4260
22. Ghanbari H, Cousins BG, Seifalian AM (2011) A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS). Macromol Rapid Commun 32(14):1032-1046
23. Ghanbari H, de MA, Seifalian AM (2011) Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int J Nanomed 6:775-786
24. Gottlieb D, Kunal T, Emani S et al (2010) In vivo monitoring of function of autologous engineered pulmonary valve. J Thorac Cardiovasc Surg 139(3):723-731
25. Hildebrand DK, Wu ZJ, Mayer JE Jr et al (2004) Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng 32(8):1039-1049
26. Hoerstrup SP, Sodian R, Daebritz S et al (2000) Functional living trileaflet heart valves grown in vitro. Circulation 102(19 Suppl 3):III44-III49
27. Hong H, Dong N, Shi J et al (2009) Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study. Artif Organs 33(7):554-558
28. Hong H, Dong N, Shi J et al (2009) Fabrication of a novel hybrid scaffold for tissue engineered heart valve. J Huazhong Univ Sci Technolog Med Sci 29(5):599-603
29. Huang HY, Liao J, Sacks MS (2007) In-situ deformation of the aortic valve interstitial cell nucleus under diastolic loading. J Biomech Eng 129(6):880-889 (Pubitemid 351153476)
30. Kannan RY, Salacinski HJ, Sales KM et al (2006) The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys 45(2):129-136 (Pubitemid 43997987)
31. Kannan RY, Salacinski HJ, Odlyha M et al (2006) The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials 27(9):1971-1979 (Pubitemid 41759491)
32. Kidane AG, Burriesci G, Edirisinghe M et al (2009) A novel nanocomposite polymer for development of synthetic heart valve leaflets. Acta Biomater 5(7):2409-2417
33. Kobayashi N, Yasu T, Ueba H et al (2004) Mechanical stress promotes the expression of smooth muscle-like properties in marrow stromal cells. Exp Hematol 32(12):1238-1245 (Pubitemid 39601129)
34. Lu X, Zhai W, Zhou Y et al (2010) Crosslinking effect of nordihydroguaiaretic acid (NDGA) on decellularized heart valve scaffold for tissue engineering. J Mater Sci Mater Med 21(2): 473-480
35. Lutter G, Metzner A, Jahnke T et al (2010) Percutaneous tissueengineered pulmonary valved stent implantation. Ann Thorac Surg 89(1):259-263
36. Malchesky PS (2010) Artificial organs 2009: a year in review. Artif Organs 34(3):242-266
37. Martin DJ, Warren LA, Gunatillake PA et al (2000) Polydimethylsiloxane/ polyether-mixed macrodiol-based polyurethane elastomers: biostability. Biomaterials 21(10):1021-1029 (Pubitemid 30145693)
38. Martin I, Wendt D, Heberer M (2004) The role of bioreactors in tissue engineering. Trends Biotechnol 22(2):80-86 (Pubitemid 38130175)
39. Mathur AB, Collier TO, Kao WJ et al (1997) In vivo biocompatibility and biostability of modified polyurethanes. J Biomed Mater Res 36(2):246-257 (Pubitemid 27330048)
40. McCarthy SJ, Meijs GF, Mitchell N et al (1997) In-vivo degradation of polyurethanes: transmission-FTIR microscopic characterization of polyurethanes sectioned by cryomicrotomy. Biomaterials 18(21):1387-1409 (Pubitemid 27480602)
41. Mendelson K, Schoen FJ (2006) Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34(12):1799-1819 (Pubitemid 44770835)
42. Metzner A, Stock UA, Iino K et al (2010) Percutaneous pulmonary valve replacement: autologous tissue-engineered valved stents. Cardiovasc Res 88(3):453-461
43. Migneco F, Hollister SJ, Birla RK (2008) Tissue-engineered heart valve prostheses: "state of the heart". Regen Med 3(3):399-419
44. Mohammadi H, Bahramian F, Wan W (2009) Advanced modeling strategy for the analysis of heart valve leaflet tissue mechanics using high-order finite element method. Med Eng Phys 31(9):1110-1117
45. Mol A, Driessen NJ, Rutten MC et al (2005) Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 33(12):1778-1788 (Pubitemid 43037548)
46. Mol A, Smits AI, Bouten CV et al (2009) Tissue engineering of heart valves: advances and current challenges. Expert Rev Med Devices 6(3):259-275
47. Neidert MR, Tranquillo RT (2006) Tissue-engineered valves with commissural alignment. Tissue Eng 12(4):891-903 (Pubitemid 43726530)
48. Park JS, Chu JS, Cheng C et al (2004) Differential effects of equiaxial and uniaxial strain on mesenchymal stem cells. Biotechnol Bioeng 88(3):359-368 (Pubitemid 39524254)
49. Ramaswamy S, Gottlieb D, Engelmayr GC Jr et al (2010) The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells. Biomaterials 31(6):1114-1125
50. Sacks MS, Mirnajafi A, Sun W et al (2006) Bioprosthetic heart valve heterograft biomaterials: structure, mechanical behavior and computational simulation. Expert Rev Med Devices 3(6): 817-834 (Pubitemid 46017622)
51. Sacks MS, Schoen FJ, Mayer JE (2009) Bioengineering challenges for heart valve tissue engineering. Annu Rev Biomed Eng 11: 289-313
52. Salacinski HJ, Tai NR, Carson RJ et al (2002) In vitro stability of a novel compliant poly(carbonate-urea)urethane to oxidative and hydrolytic stress. J Biomed Mater Res 59(2):207-218 (Pubitemid 33126623)
53. Sales VL, Mettler BA, Engelmayr GC Jr et al (2010) Endothelial progenitor cells as a sole source for ex vivo seeding of tissueengineered heart valves. Tissue Eng Part A 16(1):257-267
54. Schaefermeier PK, Szymanski D, Weiss F et al (2009) Design and fabrication of three-dimensional scaffolds for tissue engineering of human heart valves. Eur Surg Res 42(1):49-53
55. Schleicher M, Wendel HP, Fritze O et al (2009) In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 4(4):613-619
56. Schoen FJ, Levy RJ (2005) Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79(3):1072-1080 (Pubitemid 40288798)
57. Simmons CA, Matlis S, Thornton AJ et al (2003) Cyclic strain enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-regulated kinase (ERK1/2) signaling pathway. J Biomech 36(8):1087-1096 (Pubitemid 36794104)
58. Simmons A, Hyvarinen J, Odell RA et al (2004) Long-term in vivo biostability of poly(dimethylsiloxane)/poly(hexamethylene oxide) mixed macrodiol-based polyurethane elastomers. Biomaterials 25(20):4887-4900 (Pubitemid 38520819)
59. Sodian R, Sperling JS, Martin DP et al (2000) Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering. Tissue Eng 6(2):183-188 (Pubitemid 30227173)
60. Sodian R, Lueders C, Kraemer L et al (2006) Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg 81(6):2207-2216 (Pubitemid 43792354)
61. Sodian R, Schaefermeier P, Abegg-Zips S et al (2010) Use of human umbilical cord blood-derived progenitor cells for tissueengineered heart valves. Ann Thorac Surg 89(3):819-828
62. Stokes KB (1988) Polyether polyurethanes: biostable or not? J Biomater Appl 3(2):228-259
63. SutherlandFW, Perry TE, Yu Y, et al (2005) Fromstemcells to viable autologous semilunar heart valve. Circulation 111(21):2783-2791 (Pubitemid 40791550)
64. Szycher M, Demsey D, Edwards A (1999) Hydrolytically and proteolytically stable polycarbonate polyurethane silicone copolymers. US Patent 5,863,637
65. Tang YW, Labow RS, Santerre JP (2001) Enzyme-induced biodegradation of polycarbonate-polyurethanes: dependence on hard-segment chemistry. J Biomed Mater Res 57(4):597-611 (Pubitemid 32937542)
66. van Lieshout MI, Vaz CM, Rutten MC et al (2006) Electrospinning versus knitting: two scaffolds for tissue engineering of the aortic valve. J Biomate Sci Polym Ed 17(1-2):77-89 (Pubitemid 44069716)
67. Vesely I (2005) Heart valve tissue engineering. Circ Res 97(8): 743-755 (Pubitemid 41447124)
68. Wang L, Korossis S, Ingham E et al (2008) Computational simulation of oxygen diffusion in aortic valve leaflet for tissue engineering applications. J Heart Valve Dis 17(6):700-709
69. Ward R, Anderson J, McVenes R et al (2006) In vivo biostability of polysiloxane polyether polyurethanes: resistance to biologic oxidation and stress cracking. J Biomed Mater Res A 77(3):580-589 (Pubitemid 47233583)
70. Yacoub MH, Takkenberg JJ (2005) Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med 2(2):60-61 (Pubitemid 40778851)
71. Ziegelmueller JA, Zaenkert EK, Schams R et al (2010) Optical monitoring during bioreactor conditioning of tissue-engineered heart valves. ASAIO J 56(3):228-231
72. Zimmermana R, Gürhanb I, Muntelea C et al (2007) Enhanced biocompatibility of GPC by ion implantation and deposition. Surf Coat Technol 201:8020-8023